JP2022514704A5 - - Google Patents

Info

Publication number
JP2022514704A5
JP2022514704A5 JP2021536212A JP2021536212A JP2022514704A5 JP 2022514704 A5 JP2022514704 A5 JP 2022514704A5 JP 2021536212 A JP2021536212 A JP 2021536212A JP 2021536212 A JP2021536212 A JP 2021536212A JP 2022514704 A5 JP2022514704 A5 JP 2022514704A5
Authority
JP
Japan
Prior art keywords
seq
comp
fusion protein
glycosylated
tag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021536212A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022514704A (ja
JP7699543B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/059893 external-priority patent/WO2020131236A1/en
Publication of JP2022514704A publication Critical patent/JP2022514704A/ja
Publication of JP2022514704A5 publication Critical patent/JP2022514704A5/ja
Priority to JP2024214739A priority Critical patent/JP2025032259A/ja
Application granted granted Critical
Publication of JP7699543B2 publication Critical patent/JP7699543B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021536212A 2018-12-21 2019-11-05 O結合型グリコシル化認識モチーフ Active JP7699543B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024214739A JP2025032259A (ja) 2018-12-21 2024-12-09 O結合型グリコシル化認識モチーフ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862783971P 2018-12-21 2018-12-21
US62/783,971 2018-12-21
PCT/US2019/059893 WO2020131236A1 (en) 2018-12-21 2019-11-05 O-linked glycosylation recognition motifs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024214739A Division JP2025032259A (ja) 2018-12-21 2024-12-09 O結合型グリコシル化認識モチーフ

Publications (3)

Publication Number Publication Date
JP2022514704A JP2022514704A (ja) 2022-02-14
JP2022514704A5 true JP2022514704A5 (cg-RX-API-DMAC7.html) 2022-11-11
JP7699543B2 JP7699543B2 (ja) 2025-06-27

Family

ID=71101542

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021536212A Active JP7699543B2 (ja) 2018-12-21 2019-11-05 O結合型グリコシル化認識モチーフ
JP2024214739A Withdrawn JP2025032259A (ja) 2018-12-21 2024-12-09 O結合型グリコシル化認識モチーフ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024214739A Withdrawn JP2025032259A (ja) 2018-12-21 2024-12-09 O結合型グリコシル化認識モチーフ

Country Status (7)

Country Link
US (1) US12350342B2 (cg-RX-API-DMAC7.html)
EP (1) EP3897685B1 (cg-RX-API-DMAC7.html)
JP (2) JP7699543B2 (cg-RX-API-DMAC7.html)
AU (1) AU2019404924B2 (cg-RX-API-DMAC7.html)
CA (1) CA3124312A1 (cg-RX-API-DMAC7.html)
ES (1) ES3055827T3 (cg-RX-API-DMAC7.html)
WO (1) WO2020131236A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10265391B2 (en) 2015-02-26 2019-04-23 Vaxnewmo Llc Acinetobacter O-oligosaccharyltransferases and uses thereof
ES3051337T3 (en) 2018-06-16 2025-12-26 Vaxnewmo Llc Glycosylated comp pilin variants, methods of making and uses thereof
US12350342B2 (en) 2018-12-21 2025-07-08 Vaxnewmo Llc O-linked glycosylation recognition motifs
EP4271417A4 (en) * 2020-12-31 2024-11-27 Vaxnewmo Llc GLYCOSYLATED KLEBSIELLA PNEUMONIAE O-ANTIGEN AND METHODS OF PREPARATION AND USES THEREOF
JP2024517754A (ja) * 2021-04-28 2024-04-23 ヴァックスニューモ エルエルシー O-結合型グリコシル化に十分な最小シークオン
CN115120712B (zh) * 2022-06-30 2025-11-18 中国人民解放军军事科学院军事医学研究院 肺炎链球菌糖蛋白生物结合疫苗及其制备方法和应用
AU2023356184A1 (en) * 2022-10-07 2025-04-17 Vaxnewmo Llc Moraxellaceae o -linking oligosaccharyltransferases, glycosylation fragments, and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5892019A (en) 1987-07-15 1999-04-06 The United States Of America, As Represented By The Department Of Health And Human Services Production of a single-gene-encoded immunoglobulin
US9238830B2 (en) 2006-12-13 2016-01-19 The Governors Of The University Of Alberta Methods and systems for O-glycosylating proteins
US20130196410A1 (en) * 2010-03-05 2013-08-01 Alnylam Pharmaceuticals, Inc Compositions and methods for modifying the glycosylation pattern of a polypeptide
EP2742355B1 (en) 2011-08-12 2018-12-19 The Governors of the University of Alberta Method of diagnosing bacterial infections using bacterial glycoproteins
IN2014CN04076A (cg-RX-API-DMAC7.html) 2011-11-04 2015-10-23 Univ Cornell
KR20150068998A (ko) 2012-10-12 2015-06-22 글리코박신 아게 숙주 세포 변형 방법
EP2917351B1 (en) * 2012-11-07 2018-12-19 GlaxoSmithKline Biologicals S.A. Production of recombinant vaccine in e. coli by enzymatic conjugation
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
JP6356229B2 (ja) 2013-06-04 2018-07-11 アイコン ジェネティクス ゲーエムベーハー 植物産生糖タンパク質及び組換え糖タンパク質のn−グリコシル化部位占有率を調節する方法
US9988426B2 (en) 2014-09-18 2018-06-05 University Of Maryland, Baltimore Broad spectrum conjugate vaccine to prevent Klebsiella pneumoniae and Pseudomonas aeruginosa infections
SI3240895T1 (sl) * 2014-12-30 2022-04-29 Glaxosmithkline Biologicals S.A. Sestavki in postopki za glikozilacijo proteinov
US10265391B2 (en) * 2015-02-26 2019-04-23 Vaxnewmo Llc Acinetobacter O-oligosaccharyltransferases and uses thereof
US11279943B2 (en) * 2017-01-17 2022-03-22 Bioapplications Inc. Recombinant vector for expressing target protein in plant cell
EP3492481A1 (en) 2017-11-30 2019-06-05 Vaxxilon AG Vaccine against klebsiella pneumoniae
ES3051337T3 (en) * 2018-06-16 2025-12-26 Vaxnewmo Llc Glycosylated comp pilin variants, methods of making and uses thereof
JP7551618B2 (ja) 2018-12-12 2024-09-17 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム O-結合型グリコシル化のための修飾キャリアタンパク質
US12350342B2 (en) 2018-12-21 2025-07-08 Vaxnewmo Llc O-linked glycosylation recognition motifs

Similar Documents

Publication Publication Date Title
JP2021528059A5 (cg-RX-API-DMAC7.html)
ES2657588T3 (es) Vacunas de bioconjugados de bacterias grampositivas capsulares
US12173033B2 (en) Immunogenic fusion protein
RU2005119640A (ru) Множественные варианты менингококкового белка nmbi1870
JP2023531242A5 (cg-RX-API-DMAC7.html)
HRP20240847T1 (hr) Novi polisaharid i njegove upotrebe
CN116209753A (zh) 肺炎克雷伯氏菌o-抗原疫苗
JP2002541808A (ja) ポリサッカリド結合体ワクチンのための組換えトキシンaタンパク質キャリア
EP2292644A2 (en) Small Streptococcus pyogenes antigens and their use
RU2002117308A (ru) 85 кДа АНТИГЕН NEISSERIA
US20190248841A1 (en) Immunogenic Composition
AU2019404924B2 (en) O-linked glycosylation recognition motifs
JP5744842B2 (ja) 髄膜炎菌と肺炎球菌との結合型ワクチン及びそれを使用する方法
CN111801343A (zh) 免疫原性组合物
TW202304504A (zh) 大腸桿菌o18生物軛合物之生產
JP5661744B2 (ja) 腸球菌由来のポリペプチド、及びワクチン接種のためのその使用
CN111741765A (zh) 免疫原性组合物
JP2024517754A5 (cg-RX-API-DMAC7.html)
AU733845B2 (en) Immunogenic complex, use, method of preparation thereof and vaccine containing same
CN107847578A (zh) 免疫原性组合物
JP6230991B2 (ja) エンテロコッカス・フェシウムクローナルコンプレックス17に由来するラムノ多糖及びその使用
EP0595188B1 (en) Process for producing vaccine for a bacterial toxin belonging to the RTX toxin family
JP2025514731A5 (cg-RX-API-DMAC7.html)
JP2021526547A5 (cg-RX-API-DMAC7.html)
JP2020537488A5 (cg-RX-API-DMAC7.html)